We are live on
!
Find out more
Hudson Bay Capital Management Portfolio holdings
AUM
$29B
1-Year Est. Return
30.2%
This Fund
S&P 500
This Quarter
Est. Return
-1.15%
1 Year Est. Return
+30.2%
3 Year Est. Return
+99.99%
5 Year Est. Return
+135.78%
10 Year Est. Return
+498.47%
AUM
$29B
AUM Growth
-$1.36B
(-4.5%)
Cap. Flow
-$1.03B
Cap. Flow
% of AUM
-3.55%
Top 10 Holdings %
Top 10 Hldgs %
27.32%
Holding
1,717
New
560
Increased
295
Reduced
288
Closed
339
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$221M |
| 2 |
UnitedHealth
UNH
|
+$208M |
| 3 |
Micron Technology
MU
|
+$196M |
| 4 |
TSMC
TSM
|
+$173M |
| 5 |
Oracle
ORCL
|
+$134M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CYBR
CyberArk
CYBR
|
+$232M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$217M |
| 3 |
Vertiv
VRT
|
+$213M |
| 4 |
Costco
COST
|
+$188M |
| 5 |
BP
BP
|
+$170M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.15% |
| 2 | Financials | 8.94% |
| 3 | Consumer Discretionary | 6.12% |
| 4 | Healthcare | 5.51% |
| 5 | Communication Services | 3.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Sutro Biopharma
STRO
$400M
| $368K | ﹤0.01% |
+14,768
| New | +$267K |
|
1002
International Seaways
INSW
$4.61B
| $359K | ﹤0.01% |
+4,920
| New | +$315K |
|
|
URG
1003
Ur-Energy
URG
$521M
| $357K | ﹤0.01% |
239,310
+79,520
| +50% | +$130K |
|
|
AERO
1004
Grupo Aeromexico SAB de CV
AERO
$2.3B
| $350K | ﹤0.01% |
25,000
| – | – |
|
1005
C4 Therapeutics
CCCC
$402M
| $342K | ﹤0.01% |
130,081
+18,530
| +17% | +$43.6K |
|
1006
Aemetis
AMTX
$115M
| $341K | ﹤0.01% |
+106,836
| New | +$194K |
|
1007
Krystal Biotech
KRYS
$9.55B
| $336K | ﹤0.01% |
+1,300
| New | +$346K |
|
|
VSXY
1008
Victoria's Secret
VSXY
$7.43B
| $329K | ﹤0.01% |
+7,090
| New | +$396K |
|
1009
StepStone Group
STEP
$4.14B
| $324K | ﹤0.01% |
6,780
-153,014
| -96% | -$8.84M |
|
1010
Virgin Galactic
SPCE
$377M
| $317K | ﹤0.01% |
130,337
+39,704
| +44% | +$108K |
|
1011
Calumet Specialty Products
CLMT
$3.65B
| $315K | ﹤0.01% |
+8,780
| New | +$227K |
|
|
GSRFR
1012
GSR IV Acquisition Corp Rights
GSRFR
| $314K | ﹤0.01% |
128,571
| – | – |
|
1013
Taylor Devices
TAYD
$171M
| $310K | ﹤0.01% |
+5,447
| New | +$419K |
|
|
WLTH
1014
Wealthfront Corp
WLTH
$1.44B
| $310K | ﹤0.01% |
33,478
+15,428
| +85% | +$141K |
|
1015
Kymera Therapeutics
KYMR
$8.75B
| $309K | ﹤0.01% |
+3,710
| New | +$294K |
|
|
OS
1016
DELISTED
OneStream Inc
OS
| $307K | ﹤0.01% |
12,793
-58,129
| -82% | -$1.36M |
|
1017
Essential Properties Realty Trust
EPRT
$6.62B
| $306K | ﹤0.01% |
+10,080
| New | +$319K |
|
1018
MacroGenics
MGNX
$255M
| $303K | ﹤0.01% |
+104,754
| New | +$223K |
|
1019
Orchestra BioMed
OBIO
$249M
| $302K | ﹤0.01% |
71,134
+21,709
| +44% | +$92.4K |
|
|
NSRX
1020
Nasus Pharma
NSRX
$39.7M
| $299K | ﹤0.01% |
+134,771
| New | +$696K |
|
1021
InfuSystem Holdings
INFU
$236M
| $299K | ﹤0.01% |
32,385
+1,877
| +6% | +$16.4K |
|
1022
Everspin Technologies
MRAM
$367M
| $295K | ﹤0.01% |
33,561
+4,825
| +17% | +$53.1K |
|
1023
Werner Enterprises
WERN
$2.21B
| $294K | ﹤0.01% |
+10,000
| New | +$324K |
|
1024
Relmada Therapeutics
RLMD
$564M
| $293K | ﹤0.01% |
42,141
+15,894
| +61% | +$75.2K |
|
1025
Microbot Medical
MBOT
$121M
| $292K | ﹤0.01% |
+121,082
| New | +$270K |
|
Similar funds
PCH
N
Hudson Bay Capital Management's Q1 2026 Portfolio in Review
As of Q1 2026, Hudson Bay Capital Management held 1,717 positions worth $29B, down 4.5% from $30.3B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Hudson Bay Capital Management withdrew a net $1.03B in Q1 2026, closing 339 positions and reducing 288 holdings. Its most notable exit was CyberArk, an estimated $232M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Hudson Bay Capital Management opened a new position in UnitedHealth worth $189M.
- Hudson Bay Capital Management's largest Q1 2026 buy was UnitedHealth: 700,000 shares worth $189M.
- Hudson Bay Capital Management added most to Apple in Q1 2026, an estimated $221M increase.
- Hudson Bay Capital Management's biggest Q1 2026 reduction was Alphabet (Google) Class A, cutting an estimated $217M.
- Hudson Bay Capital Management fully exited CyberArk in Q1 2026, selling an estimated $232M.
- Hudson Bay Capital Management's ten largest holdings make up 27% of its $29B portfolio in Q1 2026.
- Hudson Bay Capital Management opened 560 new positions and closed 339 in Q1 2026.
- Hudson Bay Capital Management's portfolio value fell 4.5% quarter-over-quarter to $29B.
Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.